Pruebas diagnósticas para la COVID-19: la importancia del antes y el después

Autores/as

DOI:

https://doi.org/10.24265/horizmed.2020.v20n2.14

Palabras clave:

Infecciones por coronavirus, Diagnóstico, RT-PCR

Resumen

En 2019, en la cuidad de Wuhan, China, se detectaron pacientes infectados con un nuevo coronavirus denominado 2019-nCoV, hoy SARS-CoV-2. El alarmante crecimiento de esta pandemia hace necesario conocer e implementar métodos de diagnóstico confiables para detectar y tratar adecuadamente a los pacientes, lo que contribuirá a frenar la propagación de la enfermedad. La necesidad de tener profesionales entrenados en la toma de muestras, en las buenas prácticas de laboratorio clínico y en el manejo de técnicas moleculares y hematológicas es de suma importancia para identificar adecuadamente la infección con este virus. La estandarización de los protocolos de obtención, traslado y almacenamiento de la muestra es igualmente relevante para detener la expansión de la pandemia de COVID-19 causada por el SARS-CoV-2.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

World Health Organization. Novel Coronavirus (2019-nCoV)Situation reports. 2020. Disponible en: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.

GenBank. Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, complete genome. GenBank. 2020.

Li C, Yang Y, Ren L. Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species. Infect Genet Evol. 2020; 82: 104285.

Ji W, Wang W, Zhao X, Zai J, Li X. Cross-species transmission of the newly identified coronavirus 2019-nCoV. J Med Virol. 2020; 92(4): 433-40.

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224): 565-74.

Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020; 5(2020): 536-44.

Lippi G, Plebani M, Graber ML. Building a bridge to safe diagnosis in health care: the role of the clinical laboratory. Clin Chem Lab Med. 2016; 54: 1-3.

Peiris JS, Yuen KY, Osterhaus AD, Stöhr K. The severe acute respiratory syndrome. N Engl J Med. 2003; 349(25): 2431-41.

Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, et al. Analysis of therapeutic targets for SARS- CoV-2 and discovery of potential drogs by computational methods. Acta Pharm Sin B. 2020.

Enjuanes L, Almazan F, Sola I, Zuniga S. Biochemical aspects of coronavirus replication and virus-host interaction. Annu Rev Microbiol. 2006; 60: 211-30.

Belouzard S, Millet JK, Licitra BN, Whittaker GR. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses. 2012; 4: 1011-33.

Walls AC, Park Y, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020.

Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 a study of a family cluster. Lancet. 2020; 395(10223): 514-23.

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798): 270-3.

Liu R, Han H, Liu F, Lv Z, Wu K, Liu Y, et al. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020. Clin Chim Acta. 2020; 505: 172-5.

Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu D, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020; 25(3): 2000045.

Corman VM, Müller MA, Costabel U, Timm J, Binger T, Meyer B, et al. Assays for laboratory confirmation of Novel human Coronavirus (hCoV-EMC) Infections. Euro Surveill. 2012; 17(49).

Lippi G, Simundic AM, Plebani M. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clin Chem Lab Med. 2020.

Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID19) in China: a report of 1014 cases. Radiology. 2020: 200642.

Long C, Xu H, Shen Q, Zhang X, Fan B, Wang C, et al. Diagnosis of the coronavirus disease (COVID-19): rRT-PCR or CT?. Eur J Radiol. 2020; 126: 108961.

Shen Z, Xiao Y, Kang L, Ma W, Shi L, Zhang L, et al. Genomic diversity of SARS-CoV-2 in coronavirus disease 2019 patients. Clin Infect Dis. 2020.

Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020; 38(1): 1-9.

Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et.al. Coronavirus infections and immune responses. J Med Virol. 2020; 92(4): 424-32.

Dong X, Cao Y, Lu X, Zhang J, Du H, Yan Y, et al. Eleven faces of coronavirus disease 2019. Allergy. 2020.

Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020.

Irving SA, Vandermause MF, Shay DK, Belongia EA. Comparison of nasal and nasopharyngeal swabs for influenza detection in adults. Clin Med Res. 2012; 10: 215-8.

Spencer S, Gaglani M, Naleway A, Reynolds S, Ball S, Bozeman S, et al. Consistency of influenza a virus detection test results across respiratory specimen collection methods using real-time reverse transcription-PCR. J Clin Microbiol. 2013; 51: 3880-2.

Espy MJ, Uhl JR, Sloan LM, Buckwalter SP, Jones MF, Vetter EA, et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev. 2006; 19: 165-256.

Van Zyl G, Maritz J, Newman H, Preiser W. Lessons in diagnostic virology: expected and unexpected sources of error. Rev Med Virol. 2019; 29: e2052.

Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19): Guidelines for Clinical Specimens. 2020. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html

##submission.downloads##

Publicado

2020-04-04

Cómo citar

1.
Aguilar Ramírez P, Enriquez Valencia Y, Quiroz Carrillo C, Valencia Ayala E, de León Delgado J, Pareja Cruz A. Pruebas diagnósticas para la COVID-19: la importancia del antes y el después. Horiz Med [Internet]. 4 de abril de 2020 [citado 28 de marzo de 2024];20(2):e1231. Disponible en: https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/1231

Número

Sección

Artículos de revisión

Artículos más leídos del mismo autor/a